Molecular oncology for solid tumors involves analyzing cancer-specific genetic and molecular alterations to guide precise diagnosis, prognosis, and treatment. Using advanced techniques like next-generation sequencing (NGS), PCR, and FISH, clinicians can identify mutations, gene fusions, and expression profiles driving tumor growth. These insights enable targeted therapies, immunotherapy selection, and monitoring of minimal residual disease. Personalized treatment plans improve outcomes, reduce toxicity, and avoid ineffective regimens. Molecular profiling also supports early detection, risk assessment, and clinical trial eligibility. By integrating molecular diagnostics into oncology, clinicians can transform cancer care from a one-size-fits-all approach to highly tailored, patient-specific interventions.
